Aquilo Capital Management, LLC Portfolio Holdings

Aquilo Capital Management, LLC

  • $51.3 Million
  • Q1 2025

Aquilo Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $51.3 Million distributed in 13 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Blueprint Medicines Corp with a value of $7.43M, Arrowhead Pharmaceuticals, Inc. with a value of $7.01M, Protagonist Therapeutics, Inc with a value of $3.95M, Kymera Therapeutics, Inc. with a value of $3.79M, and Arvinas, Inc. with a value of $2.53M.

Examining the 13F form we can see an decrease of $12.9M in the current position value, from $64.3M to 51.3M.

Aquilo Capital Management, LLC is based out at San Francisco, CA

Below you can find more details about Aquilo Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $51.3 Million
Healthcare: $51.3 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 13
  • Current Value $51.3 Million
  • Prior Value $64.3 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email